London, UK, 6 July 2011
Chiltern Announces New Legal Entity in Israel
Chiltern International Limited (Chiltern), a global clinical contract research organization (CRO), announced that the company has established a new legal entity in Israel.

Chiltern has experienced a healthy number of requests from our clients in this region and forming a legal entity is a natural progression to our work there,” commented Armand Czaplinski, Chiltern’s Executive Director, Global Country Management, who will be leading the effort in Israel. “Israel is an attractive location to conduct clinical trials as it has many key opinion leaders (KOL) in clinical research and outstanding quality of research. Israel has some of the most skilled and educated work forces with the highest number of doctors, scientists and engineers per capita than any other country. Another key advantage is that the majority of Israel’s population belongs to the same health maintenance organization and this facilitates quick start for clinical trials and reduces the overall project timelines.

Download the Press Release

Back to headlines

In The Media
Chiltern acquires Pacific Clinical Research Pte Limited and expands operations and therapeutic depth in Asia-Pacific, 29 September 2014 More
Chiltern will Exhibit During European Society for Medical Oncology (ESMO) in Madrid , 24 September 2014 More
Chiltern Business Development Team Meets Leading Pharma Executives During Clinical Outsourcing Strategies, 16 September 2014 More
Chiltern Announces that Recently Acquired Ockham Named to 2014 Inc. 5000, 11 September 2014 More
Chiltern VP Romberg to Present Case Study During Global Trials Session; As Executive Sponsor, Chiltern Leverages Conference to Promote Clinical Research, 8 September 2014 More